A phase Phase I/II study of invariant natural killer T-cells for the treatment of cancer.
Phase of Trial: Phase I/II
Latest Information Update: 30 Mar 2016
At a glance
- Drugs Natural killer cell stimulants (Primary)
- Indications Cancer
- Focus Adverse reactions; First in man; Therapeutic Use
- 30 Mar 2016 New trial record